Related Experiment Videos
Five-year retrospective study of hospitalization and treatment of patients with sickle cell anemia
Insights
This study analyzed 463 hospital admissions for sickle cell anemia patients, revealing common treatments like fluids and anti-infection drugs. Findings highlight the need for comprehensive health planning for sickle cell disease management.
Area of Science:
- Hematology
- Public Health
- Health Services Research
Background:
- Sickle cell anemia is a prevalent genetic blood disorder requiring significant healthcare resources.
- Understanding patient admission patterns and treatment modalities is crucial for effective healthcare planning.
Purpose of the Study:
- To analyze hospital admission data for patients with sickle cell anemia.
- To identify key demographic, treatment, and outcome characteristics of these admissions.
- To inform health planners on resource allocation for sickle cell disease care.
Main Methods:
- Retrospective analysis of computerized hospital records.
- Inclusion of 463 admissions from 255 patients with sickle cell anemia.
- Data extraction on patient demographics, admission services, treatments, length of stay, readmissions, mortality, and payment sources.
Main Results:
- Admissions spanned all ages, with a mean age of 17.7 years; males constituted 54% of admissions despite being fewer in number.
- Common treatments included fluids/blood derivatives (60%) and anti-infection drugs (40%).
- Mean hospital stay was 14.75 days, double the average; 36% of patients had multiple admissions, and mortality was 1.3%.
Conclusions:
- Sickle cell anemia admissions are resource-intensive, characterized by prolonged hospital stays and frequent readmissions.
- Targeted interventions and comprehensive services are essential for managing this chronic condition.
- Financial aspects, with 51% of payments via Blue Cross or Medicaid, indicate a need for specific financial support strategies.
Abstract:
Examination of computerized hospital records of 463 admissions of 255 patients with sickle cell anemia was made. Patients ranged in age from infancy to 65, with a mean age of 17-7 years. Only 119 of the 255 patients were male, but 54% of the admissions were for males. Most patients were admitted to pediatrics and internal medicine services. Fluids and blood derivatives were given in over 60% of cases and anti-infection drugs in 40%. Mean hospital stay was 14.75 days, twice the mean for other patients. Thirty-six percent of the patients were admitted more than once. Mortality was 1.3% for the 463 admissions. Blue Cross or Medicaid accounted for payment in 51% of admissions. This information can be helpful to health planners providing comprehensive services for sickle cell patients.